• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体卒中的影像学和临床结局:保守治疗与早期手术干预的比较

Radiological and clinical outcomes of pituitary apoplexy: comparison of conservative management versus early surgical intervention.

作者信息

Shepard Matthew J, Snyder M Harrison, Soldozy Sauson, Ampie Leonel L, Morales-Valero Saul F, Jane John A

机构信息

1Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia.

2Department of Neurosurgery, MD Anderson Cancer Center, Houston, Texas; and.

出版信息

J Neurosurg. 2021 Apr 30;135(5):1310-1318. doi: 10.3171/2020.9.JNS202899. Print 2021 Nov 1.

DOI:10.3171/2020.9.JNS202899
PMID:33930863
Abstract

OBJECTIVE

Early surgical intervention for patients with pituitary apoplexy (PA) is thought to improve visual outcomes and decrease mortality. However, some patients may have good clinical outcomes without surgery. The authors sought to compare the radiological and clinical outcomes of patients with PA who were managed conservatively versus those who underwent early surgery.

METHODS

Patients with symptomatic PA were identified. Radiological, endocrinological, and ophthalmological data were reviewed. Patients with progressive visual deterioration or ophthalmoplegia were candidates for early surgery (within 7 days). Patients without visual symptoms or whose symptoms improved on high-dose steroids were treated conservatively. Log-rank and univariate analysis compared clinical and radiological outcomes between those receiving early surgery and those who underwent intended conservative management.

RESULTS

Sixty-four patients with PA were identified: 47 (73.4%) underwent intended conservative management, while 17 (26.6%) had early surgery. Patients receiving early surgery had increased rates of impaired visual acuity (VA; 64.7% vs 27.7%, p = 0.009); visual field (VF) deficits (64.7% vs 19.2%, p = 0.002); and cranial neuropathies (58.8% vs 29.8%, p < 0.05) at presentation. Tumor volumes were greater in the early surgical cohort (15.1 ± 14.8 cm3 vs 4.5 ± 10.3 cm3, p < 0.001). The median clinical and radiological follow-up visits were longer in the early surgical cohort (70.0 and 64.4 months vs 26.0 and 24.7 months, respectively; p < 0.001). Among those with VA/VF deficits, visual outcomes were similar between both groups (p > 0.9). The median time to VA improvement (2.0 vs 3.0 months, p = 0.9; HR 0.9, 95% CI 0.3-3.5) and the median time to VF improvement (2.0 vs 1.5 months; HR 0.8, 95% CI 0.3-2.6, p = 0.8) were similar across both cohorts. Cranial neuropathy improvement was more common in conservatively managed patients (HR 4.8, 95% CI 1.5-15.4, p < 0.01). Conservative management failed in 7 patients (14.9%) and required surgery. PA volumes spontaneously regressed in 95.0% of patients (38/40) with successful conservative management, with a 6-month regression rate of 66.2%. Twenty-seven patients (19 in the conservative and 8 in the early surgical cohorts) responded to a prospectively administered Visual Function Questionnaire-25 (VFQ-25). VFQ-25 scores were similar across both cohorts (conservative 95.5 ± 3.8, surgery 93.2 ± 5.1, p = 0.3). Younger age, female sex, and patients with VF deficits or chiasmal compression were more likely to experience unsuccessful conservative management. Surgical outcomes were similar for patients receiving early versus delayed surgery.

CONCLUSIONS

These data suggest that a majority of patients with PA can be successfully managed without surgical intervention assuming close neurosurgical, radiological, and ophthalmological follow-up is available.

摘要

目的

垂体卒中(PA)患者早期手术干预被认为可改善视力预后并降低死亡率。然而,一些患者未经手术也可能有良好的临床结局。作者试图比较保守治疗与早期手术治疗的PA患者的影像学和临床结局。

方法

确定有症状的PA患者。回顾其影像学、内分泌学和眼科数据。视力进行性恶化或出现眼肌麻痹的患者为早期手术(7天内)候选者。无视觉症状或高剂量类固醇治疗后症状改善的患者接受保守治疗。对数秩和单因素分析比较了早期手术患者与接受预期保守治疗患者的临床和影像学结局。

结果

共确定64例PA患者:47例(73.4%)接受预期保守治疗,17例(26.6%)接受早期手术。接受早期手术的患者就诊时视力受损(VA)率增加(64.7%对27.7%,p = 0.009);视野(VF)缺损率增加(64.7%对19.2%,p = 0.002);以及颅神经病变率增加(58.8%对29.8%,p < 0.05)。早期手术组的肿瘤体积更大(15.1±14.8 cm³对4.5±10.3 cm³,p < 0.001)。早期手术组的临床和影像学随访中位时间更长(分别为70.0和64.4个月对26.0和24.7个月;p < 0.001)。在有VA/VF缺损的患者中,两组的视力结局相似(p > 0.9)。两组的VA改善中位时间(2.0对3.0个月,p = 0.9;HR 0.9,95% CI 0.3 - 3.5)和VF改善中位时间(2.0对1.5个月;HR 0.8,95% CI 0.3 - 2.6,p = 0.8)相似。保守治疗患者的颅神经病变改善更常见(HR 4.8,95% CI 1.5 - 15.4,p < 0.01)。7例患者(14.9%)保守治疗失败而需要手术。95.0%成功接受保守治疗的患者(38/40)的PA体积自发缩小,6个月的缩小率为66.2%。27例患者(保守组19例,早期手术组8例)对前瞻性发放的视觉功能问卷-25(VFQ-25)有反应。两组的VFQ-25评分相似(保守组95.5±3.8,手术组93.2±5.1,p = 0.3)。年龄较小、女性以及有VF缺损或视交叉受压的患者更可能保守治疗失败。早期手术与延迟手术患者的手术结局相似。

结论

这些数据表明,假设能进行密切的神经外科、影像学和眼科随访,大多数PA患者无需手术干预即可成功治疗。

相似文献

1
Radiological and clinical outcomes of pituitary apoplexy: comparison of conservative management versus early surgical intervention.垂体卒中的影像学和临床结局:保守治疗与早期手术干预的比较
J Neurosurg. 2021 Apr 30;135(5):1310-1318. doi: 10.3171/2020.9.JNS202899. Print 2021 Nov 1.
2
Pituitary apoplexy: how to define safe boundaries of conservative management? Early and long-term outcomes from a single UK tertiary neurosurgical unit.垂体卒中:如何确定保守治疗的安全界限?来自英国一家三级神经外科中心的早期和长期结果。
Br J Neurosurg. 2021 Jun;35(3):334-340. doi: 10.1080/02688697.2020.1812523. Epub 2020 Sep 1.
3
Pituitary Apoplexy: Description of Medical and Surgical Treatment and Clinical, Visual, and Endocrinological Outcomes During the SARS-CoV-2 Pandemic and Over Three Years.垂体卒中:SARS-CoV-2大流行期间及三年多来的内科和外科治疗描述以及临床、视觉和内分泌学结果
Cureus. 2024 Jun 25;16(6):e63152. doi: 10.7759/cureus.63152. eCollection 2024 Jun.
4
Pituitary Apoplexy: Results of Surgical and Conservative Management Clinical Series and Review of the Literature.垂体卒中:手术和保守治疗的临床系列结果及文献复习。
World Neurosurg. 2019 Oct;130:e988-e999. doi: 10.1016/j.wneu.2019.07.055. Epub 2019 Jul 11.
5
Acute management of pituitary apoplexy--surgery or conservative management?垂体卒中的急性处理——手术还是保守治疗?
Clin Endocrinol (Oxf). 2004 Dec;61(6):747-52. doi: 10.1111/j.1365-2265.2004.02162.x.
6
Presentation and outcomes in surgically and conservatively managed pediatric Rathke cleft cysts.手术治疗与保守治疗的小儿拉克氏裂囊肿的临床表现及预后
J Neurosurg Pediatr. 2018 Mar;21(3):308-314. doi: 10.3171/2017.9.PEDS17400. Epub 2017 Dec 22.
7
Management and outcomes of pituitary apoplexy.垂体卒中的管理与预后
J Neurosurg. 2015 Jun;122(6):1450-7. doi: 10.3171/2014.10.JNS141204. Epub 2015 Apr 10.
8
Visual and Endocrine Recovery Following Conservative and Surgical Treatment of Pituitary Apoplexy: A Meta-Analysis.保守治疗与手术治疗垂体卒中后视觉和内分泌功能的恢复:一项荟萃分析。
World Neurosurg. 2019 Dec;132:33-40. doi: 10.1016/j.wneu.2019.08.115. Epub 2019 Aug 27.
9
Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom.急性垂体卒中的表现、治疗和结局:来自英国的一项大型单中心经验。
Clin Endocrinol (Oxf). 2014 Mar;80(3):419-24. doi: 10.1111/cen.12307. Epub 2013 Aug 26.
10
A key role for conservative treatment in the management of pituitary apoplexy.保守治疗在垂体卒中治疗中的重要作用。
Endocrine. 2021 Jan;71(1):168-177. doi: 10.1007/s12020-020-02499-8. Epub 2020 Sep 21.

引用本文的文献

1
Pituitary apoplexy: surgical or conservative? A meta-analytical insight.垂体卒中:手术治疗还是保守治疗?一项荟萃分析见解
Front Surg. 2025 Jun 4;12:1579498. doi: 10.3389/fsurg.2025.1579498. eCollection 2025.
2
The role of intervention timing and treatment modality in visual recovery following pituitary apoplexy: a systematic review and meta-analysis.垂体卒中后视觉恢复中干预时机和治疗方式的作用:一项系统评价和荟萃分析
J Neurooncol. 2024 Dec;170(3):469-482. doi: 10.1007/s11060-024-04717-z. Epub 2024 Nov 6.
3
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center.
垂体卒中:单中心功能性和非功能性垂体腺瘤 93 例综合分析。
Pituitary. 2024 Oct;27(5):705-713. doi: 10.1007/s11102-024-01453-5. Epub 2024 Sep 13.
4
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era.垂体卒中:对COVID-19时代风险因素及最佳管理策略的重新评估
Pituitary. 2024 Dec;27(6):898-908. doi: 10.1007/s11102-024-01420-0. Epub 2024 Aug 5.
5
Comparing neuroendocrine recovery between surgical and conservative management in pituitary apoplexy patients: a propensity score-matched analysis.比较垂体卒中患者手术与保守治疗之间神经内分泌恢复的差异:倾向评分匹配分析。
Neurosurg Rev. 2024 May 28;47(1):236. doi: 10.1007/s10143-024-02461-6.
6
Predictive value of cyst/tumor volume ratio of pituitary adenoma for tumor cell proliferation.垂体腺瘤的囊/肿瘤体积比对肿瘤细胞增殖的预测价值。
BMC Med Imaging. 2024 Mar 21;24(1):69. doi: 10.1186/s12880-024-01246-z.
7
Inhibition of VEGF receptors induces pituitary apoplexy: An experimental study in mice.抑制血管内皮生长因子受体可诱发垂体卒中:一项在小鼠体内的实验研究。
PLoS One. 2023 Mar 16;18(3):e0279634. doi: 10.1371/journal.pone.0279634. eCollection 2023.
8
Risk Factors, Radiological and Clinical Outcomes in Subclinical and Clinical Pituitary Apoplexy.亚临床和临床垂体卒中的危险因素、影像学及临床结局
J Clin Med. 2022 Dec 8;11(24):7288. doi: 10.3390/jcm11247288.
9
Recovery of Complete Blindness and Internal Ophthalmoplegia After Transsphenoidal Decompression of Pituitary Apoplexy.垂体卒中经蝶窦减压术后完全性失明和眼内肌麻痹的恢复
Cureus. 2022 Sep 1;14(9):e28681. doi: 10.7759/cureus.28681. eCollection 2022 Sep.
10
Pituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms.垂体卒中:危险因素与潜在分子机制。
Int J Mol Sci. 2022 Aug 5;23(15):8721. doi: 10.3390/ijms23158721.